Tariffs threaten PBS listings: Breast Cancer Network Australia

Patients needing access to high-cost medicines are being abandoned as Trump’s tariffs prompt “pharmaceutical standoff”, advocacy group warns  Concerns are being raised that patients are being left to deteriorate as talks to list cancer treatment, Tucatinib (tukysa), on the Pharmaceutical Benefits Scheme (PBS) stall.   Breast Cancer Network Australia (BCNA) has warned that women with metastatic breast cancer were falling victim to US